Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...
MITI MURHESA, Congo (AP) — Hospitals across eastern Congo that were once at the forefront of the country’s response to the ...
In the years to come, Bavarian Nordic foresees that more commercially minded-business taking the lead over the sort of ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
MITI MURHESA, Congo — Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback